Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases

Santiago Ponce, Jordi Bruna, Oscar Juan, Rafael López, Alejandro Navarro, Ana Laura Ortega, Javier Puente, Eugènia Verger, Adela Bartolomé, Ernest Nadal

Résultats de recherche: Contribution à un journalArticle 'review'Revue par des pairs

8 Citations (Scopus)

Résumé

The presence of an epidermal growth factor receptor (EGFR) mutation is associated with higher incidence of brain metastases in patients with non-small cell lung cancer (NSCLC); however, patients with synchronous brain metastases at diagnosis have generally been excluded from clinical trials. As there is limited clinical evidence for managing this patient population, a multidisciplinary group of Spanish medical and radiation oncologists, and neuro-oncologist with expertise treating brain metastases in lung cancer patients met with the aim of reaching and developing an expert opinion consensus on the management of patients with EGFR mutated NSCLC with brain metastases. This consensus contains 26 recommendations and 20 conclusion statements across 21 questions in 7 areas, as well as a first-line treatment algorithm.

langue originaleAnglais
Pages (de - à)190-206
Nombre de pages17
journalCritical Reviews in Oncology/Hematology
Volume138
Les DOIs
étatPublié - 1 juin 2019
Modification externeOui

Contient cette citation